DigestRedComo funciona
Digest/ Comunicado

Compatibilidad
Ahorrar()
Compartir
Detalles de contacto
¿Quieres ver los próximos lanzamientos de este profesional en tu resumen?

Comunicados relacionados

02/08/2024
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Eventos
Industria
Coya Therapeutics Announces that Results from a Double-Blind Placebo-Controlled Study in Alzheimer’s Disease will be presented on October 29, 2024 at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) in Madrid
Fuente
Coya Therapeutics, Inc.
Editor
Business Wire
Descubre afinidades
0
29/10/2024
Eventos
Industria
Análisis de Mercados
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Medicina - Varios
Coya Therapeutics Announces Positive Results of a Double-Blind Study of Subcutaneous Low-Dose Interleukin-2 (LD IL-2) in Alzheimer’s Disease (AD) Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) in Madrid (Spain)
Fuente
Coya Therapeutics, Inc.
Editor
Business Wire
Descubre afinidades
0
31/07/2024
Ciencia
Asociaciones/Profesionales
Farmacéutica
Material médico sanitario
Biotecnología
Medicina - Varios
Salud
Industria
Coya Therapeutics Expands Pipeline and Intellectual Property Portfolio with Filing of New U.S. Patents for COYA 301 in Combination with Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
Fuente
Coya Therapeutics, Inc.
Editor
Business Wire
Descubre afinidades
0